← Open Payments lookup

STEVEN WOLF: Open Payments

NPI 1487645693 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$48,371 in 156 payments from 29 companies in 2025. Trend: 2023 $62,283 · 2024 $45,370 · 2025 $48,371

Speaker / faculty: $34,985Consulting: $5,926Food & beverage: $4,448Travel & lodging: $3,011
CompanyPaymentsAmount
JAZZ PHARMACEUTICALS INC.25$13,829
UCB Biosciences Inc.2$8,500
Neurelis, Inc.14$8,147
UCB, Inc.30$7,671
Monteris Medical Corporation14$4,498
Otter Pharmaceuticals, LLC7$2,778
LivaNova USA, Inc.2$1,440
SK Life Science, Inc.17$487
Supernus Pharmaceuticals, Inc.11$202
AQUESTIVE THERAPEUTICS, INC.2$115

Products named: Fintepla, EPIDIOLEX, VALTOCO, Neuroblate, SYMPAZAN, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, Qelbree, Briviact.

Industry payments across NY — which companies pay providers there.